{"id":660127,"date":"2026-05-23T08:39:23","date_gmt":"2026-05-23T08:39:23","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/660127\/"},"modified":"2026-05-23T08:39:23","modified_gmt":"2026-05-23T08:39:23","slug":"2-healthcare-stocks-worth-investigating-and-1-facing-headwinds","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/660127\/","title":{"rendered":"2 Healthcare Stocks Worth Investigating and 1 Facing Headwinds"},"content":{"rendered":"\n<p class=\"yf-1fy9kyt\">Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, limiting growth. This has capped returns as the industry\u2019s six-month gain of 7.8% has lagged the S&amp;P 500\u2019s 13.2% climb.<\/p>\n<p class=\"yf-1fy9kyt\">The elite companies can churn out earnings growth under any circumstance, however, and our mission at StockStory is to help you find them. With that said, here are two healthcare stocks boasting durable advantages and one best left ignored.<\/p>\n<p>      One Healthcare Stock to Sell:       Moderna (MRNA)    <\/p>\n<p class=\"yf-1fy9kyt\">Market Cap: $18.14 billion<\/p>\n<p class=\"yf-1fy9kyt\">Rising to global prominence during the COVID-19 pandemic with one of the first effective vaccines, Moderna (NASDAQ:MRNA) develops messenger RNA (mRNA) medicines that direct the body&#8217;s cells to produce proteins with therapeutic or preventive benefits for various diseases.<\/p>\n<p class=\"yf-1fy9kyt\">Why Do We Think MRNA Will Underperform?<\/p>\n<p class=\"yf-1fy9kyt\">Sales tumbled by 34.3% annually over the last two years, showing market trends are working against its favor during this cycle<\/p>\n<p class=\"yf-1fy9kyt\">Sales were less profitable over the last five years as its earnings per share fell by 46.5% annually, worse than its revenue declines<\/p>\n<p class=\"yf-1fy9kyt\">129.7 percentage point decline in its free cash flow margin over the last five years reflects the company\u2019s increased investments to defend its market position<\/p>\n<p class=\"yf-1fy9kyt\">Moderna is trading at $45.38 per share, or 9.9x forward price-to-sales. <a href=\"https:\/\/stockstory.org\/us\/stocks\/nasdaq\/mrna?utm_source=screener&amp;utm_medium=yahoo&amp;utm_campaign=underperformScreenerCTA&amp;utm_article=ClhzYm4BYUA%3D&amp;utm_ticker=MRNA\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:To fully understand why you should be careful with MRNA, check out our full research report (it\u2019s free);elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;To fully understand why you should be careful with MRNA, check out our full research report (it\u2019s free)&quot;}\" class=\"link \">To fully understand why you should be careful with MRNA, check out our full research report (it\u2019s free)<\/a>.<\/p>\n<p>      Two Healthcare Stocks to Watch:       Intuitive Surgical (ISRG)    <\/p>\n<p class=\"yf-1fy9kyt\">Market Cap: $156.4 billion<\/p>\n<p class=\"yf-1fy9kyt\">Pioneering minimally invasive surgery since its first da Vinci system was FDA-cleared in 2000, Intuitive Surgical (NASDAQ:ISRG) develops and manufactures robotic-assisted surgical systems that enable minimally invasive procedures across various medical specialties.<\/p>\n<p class=\"yf-1fy9kyt\">Why Do We Watch ISRG?<\/p>\n<p class=\"yf-1fy9kyt\">Impressive 20.2% annual revenue growth over the last two years indicates it\u2019s winning market share this cycle<\/p>\n<p class=\"yf-1fy9kyt\">Share buybacks catapulted its annual earnings per share growth to 21.3%, which outperformed its revenue gains over the last five years<\/p>\n<p class=\"yf-1fy9kyt\">Robust free cash flow margin of 19.6% gives it many options for capital deployment, and its recently improved profitability means it has even more resources to invest or distribute<\/p>\n<p class=\"yf-1fy9kyt\">At $442.32 per share, Intuitive Surgical trades at 41.3x forward P\/E. Is now the right time to buy? <a href=\"https:\/\/stockstory.org\/us\/stocks\/nasdaq\/isrg?utm_source=screener&amp;utm_medium=yahoo&amp;utm_campaign=introResearchReport&amp;utm_article=ClhzYm4BYUA%3D&amp;utm_ticker=MRNA\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Find out in our full research report, it\u2019s free;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Find out in our full research report, it\u2019s free&quot;}\" class=\"link \">Find out in our full research report, it\u2019s free<\/a>.<\/p>\n<p>      BrightSpring Health Services (BTSG)    <\/p>\n<p class=\"yf-1fy9kyt\">Market Cap: $11.66 billion<\/p>\n<p class=\"yf-1fy9kyt\">Founded in 1974, BrightSpring Health Services (NASDAQ:BTSG) offers home health care, hospice, neuro-rehabilitation, and pharmacy services.<\/p>\n<p class=\"yf-1fy9kyt\">Why Is BTSG on Our Radar?<\/p>\n<p class=\"yf-1fy9kyt\">Market share has increased this cycle as its 22.6% annual revenue growth over the last two years was exceptional<\/p>\n<p class=\"yf-1fy9kyt\">Revenue base of $13.65 billion gives it economies of scale and some negotiating power<\/p>\n<p class=\"yf-1fy9kyt\">Estimated revenue growth of 14.2% for the next 12 months implies its momentum over the last two years will continue<\/p>\n<p class=\"yf-1fy9kyt\">BrightSpring Health Services\u2019s stock price of $56.75 implies a valuation ratio of 31.9x forward P\/E. Is now the time to initiate a position? <a href=\"https:\/\/stockstory.org\/us\/stocks\/nasdaq\/btsg?utm_source=screener&amp;utm_medium=yahoo&amp;utm_campaign=EndResearchReport&amp;utm_article=ClhzYm4BYUA%3D&amp;utm_ticker=MRNA\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:See for yourself in our in-depth research report, it\u2019s free;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;See for yourself in our in-depth research report, it\u2019s free&quot;}\" class=\"link \">See for yourself in our in-depth research report, it\u2019s free<\/a>.<\/p>\n<p>     High-Quality Stocks for All Market Conditions   <\/p>\n<p class=\"yf-1fy9kyt\">ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.<\/p>\n<p class=\"yf-1fy9kyt\">Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. <a href=\"https:\/\/stockstory.org\/high-quality\/top-6-to-buy-this-week?utm_source=screener&amp;utm_medium=yahoo&amp;utm_campaign=EndCategory&amp;utm_content=20260301_top_6_this_week&amp;utm_article=ClhzYm4BYUA%3D&amp;utm_ticker=MRNA\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Get Our Top 6 Stocks for Free HERE;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Get Our Top 6 Stocks for Free HERE&quot;}\" class=\"link \"> Get Our Top 6 Stocks for Free HERE<\/a>.<\/p>\n<p class=\"yf-1fy9kyt\">Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). <a href=\"https:\/\/stockstory.org\/discover\/high-quality-stocks?utm_source=screener&amp;utm_medium=yahoo&amp;utm_campaign=discover&amp;utm_article=ClhzYm4BYUA%3D&amp;utm_ticker=MRNA\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Find your next big winner with StockStory today;elm:context_link;itc:0;sec:content-canvas\" data-yga=\"{&quot;yLinkElement&quot;:&quot;context_link&quot;,&quot;yModuleName&quot;:&quot;content-canvas&quot;,&quot;yLinkText&quot;:&quot;Find your next big winner with StockStory today&quot;}\" class=\"link \">Find your next big winner with StockStory today<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"Personal health and wellness is one of the many secular tailwinds for healthcare companies. But speed bumps such&hellip;\n","protected":false},"author":2,"featured_media":660128,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[283336,22449,97,252,253,133629,5728,53522,2214],"class_list":["post-660127","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-brightspring-health-services","tag-free-cash-flow","tag-health","tag-health-care","tag-healthcare","tag-intuitive-surgical","tag-market-cap","tag-research-report","tag-revenue-growth"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/660127","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=660127"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/660127\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/660128"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=660127"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=660127"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=660127"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}